MENU
CHRO
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION
Channel Therapeutics (CHRO) Ownership - Who owns Channel Therapeutics?
Channel Therapeutics Corp is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain... Show more
Profile
Industry
N/A
Address
4400 Route 9 South
Phone
+1 732 514-2636
Employees
7
Web
https://www.chromocell.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
8.09M
P/E Ratio
N/A
Total Cash
131.32K
Projected Growth
N/A
Total Debt
2.5M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.02
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
CHRO
Capitalization
8.09M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
131K
Total Cash/Share
0.02
Total Debt
2.5M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-4.2M
P/B Ratio
4.11
Cash Flow
N/A
Earnings
-1.2
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
621
Current Ratio
0.18
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-7.07M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-297.84
Shares Held By Institutions
856K
Shares Outstanding - Current
6.6M
Total Liabilities
5.11M
Total Volume MTD
N/A
Value
-1
Gain YTD
91.342
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
4400 Route 9 South
Phone
+1 732 514-2636
Employees
7
Web
https://www.chromocell.com